DYADIC INTERNATIONAL INC Public Float
DYADIC INTERNATIONAL INC (DYAI) had Public Float of $24.22 million as of 2025-06-30, per its 10-K/A filed 2026-04-30.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-30
- 2025-06-30: Entity Public Float $24.22M.
- 2024-06-30: Entity Public Float $30.48M.
- 2023-06-30: Entity Public Float $39.10M.
- 2022-06-30: Entity Public Float $60.90M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $24.22M 10-K/A · filed 2026-04-30 |
| 2024-06-30 | $30.48M 10-K · filed 2025-03-26 |
| 2023-06-30 | $39.10M 10-K · filed 2024-03-28 |
| 2022-06-30 | $60.90M 10-K · filed 2023-03-29 |
| 2021-06-30 | $83.80M 10-K · filed 2022-03-29 |
| 2020-06-30 | $238.00M 10-K/A · filed 2021-07-27 |
| 2019-06-30 | $169.70M 10-K · filed 2020-03-30 |
| 2018-06-30 | $29.80M 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |